RAC

1.20%

$1.68 race oncology ltd

Of the sounds of it, FTO is becoming lessor focus?

First 14 Last

Share
Profile

Follow
SocialEddy

326 Posts.

138

27/11/23

19:07

Post #: 71132415
Share

Originally posted by ma420: ↑

Thanks mate. Here are a few of my notes (if I recall anything else worth sharing I will):

- The phase 1a/b trial will also collect FTO data. This will then drive the phase 2 trials where again FTO data will be collected. Hence the funding of the trials (first without and later with options) will accomplish both cardio protection and FTO objectives.

- The Dan Dominissini data may never come. Dan apparently has been promoted from his role where he was collecting diagnostics data for us (among other things he did) to a senior admin role so he likely no longer works on the FTO diagnostic markers. We may never get any return on our investment for his engagement. Also if we got it, it may not be very useful given that would be based on RC110 and may not fully translate to RC220. So we may need to repeat the process of identifying FTO markers and come up with a CDx?

- SHs seem to be more comfortable with Pete and they were with DCB (hindsight, yes, I know).

- Pete seems confident that we could do a China licensing deal and not necessarily have to first price the drug in the USA (like most think) to get the max value for Bisantrene.

- Pete is working more than 2 days a week and engaged in the preclinical/ clinical discussions with the team. Clearly he has the chops for it, has understanding how critical the Chemistry, Manufacturing and Control (CMC) process is and is keen to get right the first time. He has also been around the industry long enough to see some failures at various stages, which IMO is a good thing.

- There is a general level discontentment about the money wasted since the SPP, but overall the focus is on moving ahead.

(It was good to meet a number of SHs and all the mgmt and staff. Looking forward to next time hopefully in better sentiment)

Expand

Of the sounds of it, FTO is becoming lessor focus?

RAC Price at posting: 94.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

CBA breaks trading record on strong day for Aussie financials

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

There are more pages in this discussion • 62 more messages in this thread...

First 14 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.68		Change 0.020(1.20%)		Mkt cap ! $286.2M

Open	High	Low	Value	Volume
$1.68	$1.68	$1.61	$177.8K	108.9K

Buyers (Bids)

No.	Vol.	Price($)
1	1100	$1.64

Sellers (Offers)

Price($)	Vol.	No.
$1.68	4999	1

View Market Depth

No.	Vol.	Price($)
1	31221	1.625
1	5000	1.620
1	30000	1.615
2	16249	1.610
4	26875	1.600

Price($)	Vol.	No.
1.680	4999	1
1.720	17729	2
1.730	25792	1
1.750	508	1
1.780	4483	1

Last trade - 16.10pm 06/09/2024 (20 minute delay)

RAC (ASX) Chart

Of the sounds of it, FTO is becoming lessor focus?

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

CBA breaks trading record on strong day for Aussie financials

Shekel Brainweigh investor presentation webinar – the future of retail automation

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Of the sounds of it, FTO is becoming lessor focus?

Top Stories

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

As Nvidia cools, we're looking to Aussie AI

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

CBA breaks trading record on strong day for Aussie financials

Shekel Brainweigh investor presentation webinar – the future of retail automation

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News